Company profile: Cellares
1.1 - Company Overview
Company description
- Provider of automated cell therapy manufacturing solutions, including the Cell Shuttle—a fully closed, high-throughput platform integrating all unit operations; Smart Factories for mass manufacturing; a Technology Adoption Program to automate and transfer developer processes; process and analytical development services; and clinical and commercial cGMP manufacturing through a global network of IDMO Smart Factories.
Products and services
- Clinical & Commercial cGMP Manufacturing: cGMP-compliant services utilizing a global network of IDMO Smart Factories to produce cell therapy batches across all drug development and commercialization phases using automated operations
- Smart Factories: Industrial-scale facilities equipped with Cell Shuttles that mass-produce cell therapies, engineered to output significantly more batches per year than conventional facilities through automated, standardized operations
- Cell Shuttle: A fully closed, automated platform integrating technologies for all unit operations, architected to deliver high-throughput cell therapy manufacturing with consistent, end-to-end processing in one system
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellares
Rosetta Biosoftware
HQ: United States
Website
- Description: Provider of life science informatics solutions enabling breakthroughs in basic biological research, drug discovery and development, and translational medicine. Their products accelerate research and improve safety and therapeutic decision making.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rosetta Biosoftware company profile →
Gene Logic
HQ: United States
Website
- Description: Provider of comprehensive Genomic Reference Databases and GLP-compliant Microarray Services as part of an integrated genomics offering, serving over two-thirds of the top 25 pharma companies, leading research institutes, and emerging biotech companies worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gene Logic company profile →
Valo Health
HQ: United States
Website
- Description: Provider of AI-driven therapeutics discovery and development solutions leveraging large-scale human data. Offerings include the Opal computational platform to identify and validate drug targets and enable small-molecule discovery; Target Discovery using machine learning and biomarkers; Logica, an integrated solution with Charles River Laboratories; and OPL-0401, an investigational ROCK1/2 inhibitor for diabetic retinopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valo Health company profile →
Median Technologies
HQ: France
Website
- Description: Provider of medical imaging software and services for oncology clinical trials, cancer screening, and clinical practice, standardizing and automating the interpretation of medical images to optimize diagnosis of cancer patients and assessment of their response to therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Median Technologies company profile →
Captario
HQ: Sweden
Website
- Description: Provider of a cloud-based SaaS platform and services for strategic decision-making in drug development. Captario SUM offers modeling and simulation to create, compare, and optimize project and portfolio pathways by value and risk, with visual project modeling and portfolio functionality. Services include portfolio management, project strategy analysis, managed portfolios, simulation-based portfolio forecasts, and quantitative disease area strategy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Captario company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellares
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellares
2.2 - Growth funds investing in similar companies to Cellares
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellares
4.2 - Public trading comparable groups for Cellares
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →